Possibility of magnesium supplementation for supportive treatment in patients with COVID-19

Eur J Pharmacol. 2020 Nov 5:886:173546. doi: 10.1016/j.ejphar.2020.173546. Epub 2020 Sep 12.

Abstract

Magnesium as an enzymatic activator is essential for various physiological functions such as cell cycle, metabolic regulation, muscle contraction, and vasomotor tone. A growing body of evidence supports that magnesium supplementation (mainly magnesium sulfate and magnesium oxide) prevents or treats various types of disorders or diseases related to respiratory system, reproductive system, nervous system, digestive system, and cardiovascular system as well as kidney injury, diabetes and cancer. The ongoing pandemic coronavirus disease 19 (COVID-19) characterized by respiratory tract symptoms with different degrees of important organ and tissue damages has attracted global attention. Particularly, effective drugs are still lacking in the COVID-19 therapy. In this review, we find and summarize the effectiveness of magnesium supplementation on the disorders or diseases, and provide a reference to the possibility of magnesium supplementation for supportive treatment in patients with COVID-19.

Keywords: COVID-19; Magnesium supplementation; Supportive treatment.

Publication types

  • Review

MeSH terms

  • Animals
  • COVID-19
  • Coronavirus Infections / complications
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / prevention & control
  • Dietary Supplements*
  • Humans
  • Magnesium / adverse effects
  • Magnesium / pharmacology*
  • Magnesium / therapeutic use
  • Pandemics / prevention & control
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / prevention & control
  • Safety

Substances

  • Magnesium